10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Nuvalent Inc. (NUVL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deerfield Management James E. Flynn | 19,991,024 | $2,045,081,755 | 30.55% | |
| 2. | Perceptive Advisors Joseph Edelman | 2,979,235 | $304,775,741 | +17% | 6.44% |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,193,679 | $122,113,362 | +35% | 1.02% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 940,000 | $96,162,000 | -37% | 6% |
| 5. | Driehaus Capital Richard Driehaus | 863,957 | $88,382,801 | +25% | 0.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.50 | 650,000 | Large Shareholder, Director, Other | 650,000 | 2022-11-03 | Filing | |
| $33.50 | 149,253 | Director | 3,577,267 | 2022-11-03 | Filing | |
| $17.00 | 735,000 | Director | 3,428,014 | 2021-08-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $89.98 | 1,111 | 188,113 | 2024-11-15 | Filing | ||
| $88.87 | 8,278 | 189,224 | 2024-11-15 | Filing | ||
| $87.95 | 6,068 | 197,502 | 2024-11-15 | Filing | ||
| $87.08 | 11,543 | 203,570 | 2024-11-15 | Filing | ||
| $90.03 | 500 | 33,300 | 2024-11-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,725,070 | $642,077,901 | 0.04% | |
| 2. | 3,858,008 | $283,910,809 | 13.29% | |
| 3. | 3,577,267 | $263,251,079 | 25.23% | |
| 4. | 3,339,850 | $245,779,562 | 0% | |
| 5. | 2,721,195 | $200,252,739 | 0% |
News See All
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
13 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the 13 best short squeeze stocks to buy now.
12 Small-Cap Stocks With Insider Buying
Insider buying refers to a company's officers, directors, or major shareholders purchasing shares of their own company's stock.
12 Best Small-Cap Healthcare Stocks To Buy Now
Macroeconomic headwinds and recessionary concerns will not weaken healthcare deals next year after the market experienced resilient mergers and acquisitions in 2022.